Renalytix partners with Tempus AI to expand kidney disease testing
Go back to Renalytix partners with Tempus AI to expand kidney disease testing| Oppenheimer Real Estate Fund Class N (NASDAQ: RENX) | Delayed: 1.75 +0.02 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.73 | 52 Week High | $18.34 | |||
| Open | $1.70 | 52 Week Low | $14.92 | |||
| Day High | $1.77 | P/E | N/A | |||
| Day Low | $1.70 | EPS | $0.00 | |||
| Volume | 16,313 | |||||
| (AMEX: RNLXY) | Delayed: 1.21 +0.06 (5.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.15 | 52 Week High | $ | |||
| Open | $1.21 | 52 Week Low | $ | |||
| Day High | $1.21 | P/E | N/A | |||
| Day Low | $1.21 | EPS | $ | |||
| Volume | 110 | |||||
| StemCells, Inc. (NASDAQ: TEM) | Delayed: 56.46 +1.59 (2.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.87 | 52 Week High | $0.45 | |||
| Open | $54.22 | 52 Week Low | $0.37 | |||
| Day High | $57.10 | P/E | N/A | |||
| Day Low | $53.37 | EPS | $-0.31 | |||
| Volume | 4,546,682 | |||||

